New Amgen Weight-Loss Drug Effective in Early Trials

Published on February 5, 2024

Animal and early-stage human trial data for Amgen’s experimental obesity drug published in a medical journal showed that it promoted significant weight loss with an acceptable safety profile, the company said on Monday.The dataset published in Nature Metabolism details…

Read Full Article (External Site)